Common drugs used to treat conditions such as arthritis, nerve and muscle pain, and autoimmune diseases increased anywhere from about 8 percent to 19 percent, according to an analysis published by Pharmacy Benefits Consultants, a consulting company based in New Jersey.
Earlier this year, the Democratic staff of the U.S. House of Representatives' Committee on Oversight and Government Reform used that data and published a report that showed 16 of them increased in price since the end of 2016, 14 increased by double-digit percentages, and 11 increased by more than 15 percent.
Eight of the drugs included in the report, which compared prices from Dec. 31, 2016, to March 1, 2018, are manufactured by New Jersey pharmaceutical companies.
Here's how much those Jersey drug prices increased, from least to most:
The prices come from GoodRX, the Food and Drug Administration and the official product websites.
NOTE: Prices for all medicines are subject to various discounts and rebates negotiated by insurance companies, so the actual cost can be lower for the consumer.